AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers.
Penning
Trevor M
TM
Department of Pharmacology, University of Pennsylvania School of Medicine, 3620 Hamilton Walk, Philadelphia, PA 19104-6084, USA. penning@pharm.med.upenn.edu
D000429:Alcohol Oxidoreductases / Q000494:pharmacology; D000449:Aldehyde Reductase / Q000096:biosynthesis* / Q000097:blood* / Q000494:pharmacology; D000074408:Aldo-Keto Reductases; D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000097:blood*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology*; D020869:Gene Expression Profiling; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D011379:Prognosis; D015398:Signal Transduction; D012907:Smoking / Q000009:adverse effects*; D014212:Tretinoin / Q000494:pharmacology; D015854:Up-Regulation
D014408:Biomarkers, Tumor; D014212:Tretinoin; D000429:Alcohol Oxidoreductases; C120471:AKR1B10 protein, human; D000074408:Aldo-Keto Reductases; D000449:Aldehyde Reductase